Who owns Biomarin Pharma Inc convertible/?
- CUSIP Number: 09061gah4
Tip: Access positions for across all investors
Analyze quarterly positions in Biomarin Pharma Inc convertible/ with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Biomarin Pharma Inc convertible/ stock
Who bought or sold Biomarin Pharma Inc convertible/ this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Lord, Abbett & Co | 43M | $42M | 259% | Mar 2024 |
|
| Bank of America Corporation | 30M | $30M | 127% | Mar 2024 |
|
| Millennium Management | 27M | $26M | 5% | Mar 2024 |
|
| Citigroup | 26M | $25M | 3% | Mar 2024 |
|
| Aviva | 26M | $25M | 2% | Mar 2024 |
|
| Sona Asset Management | 25M | $25M | 8% | Mar 2024 |
|
| Tenor Capital Management | 22M | $21B | 639% | Mar 2024 |
|
| Sunrise Partners Limited Partnership | 15M | $15M | 40% | Mar 2024 |
|
| Partner Fund Management | 15M | $15M | 0% | Dec 2023 |
|
| Moore Capital Management | 13M | $13M | 100% | Mar 2024 |
|
| Thrivent Financial for Lutherans | 10M | $10M | 0% | Mar 2024 |
|
| MacKay Shields | 8.8M | $8.7M | -3% | Mar 2024 |
|
| Jpmorgan Chase & Co | 8.4M | $8.3M | -19% | Mar 2024 |
|
| Palisade Capital Management | 8.0M | $7.8M | -8% | Mar 2024 |
|
| Opti Capital Management | 7.6M | $7.5M | 100% | Mar 2024 |
|
| Man Group | 7.5M | $7.4M | 0% | Mar 2024 |
|
| Royal Bank of Canada | 6.7M | $6.7M | 1% | Mar 2024 |
|
| Sonora Investment Management Group | 6.1M | $6.0M | -3% | Mar 2024 |
|
| Wells Fargo & Company | 5.2M | $5.1M | 50% | Mar 2024 |
|
| DLD Asset Management | 5.0M | $4.9M | 100% | Dec 2023 |
|
| Bnp Paribas Arbitrage, Snc | 4.3M | $4.2M | -11% | Mar 2024 |
|
| Bnp Paribas Investment Partners | 3.5M | $3.4M | 0% | Mar 2024 |
|
| Jane Street | 2.6M | $2.5M | -4% | Mar 2024 |
|
| Leucadia National Corporation | 2.5M | $2.5M | 1465% | Mar 2024 |
|
| Lazard Asset Management | 2.5M | $2.5M | 0% | Dec 2023 |
|
| Morgan Stanley | 2.3M | $2.3M | -83% | Mar 2024 |
|
| Bank Of Montreal | 2.1M | $2.1M | -36% | Mar 2024 |
|
| Citadel Advisors | 2.0M | $2.0M | -50% | Mar 2024 |
|
| Branch Banking & Trust Company | 2.0M | $1.9M | -9% | Mar 2024 |
|
| Nicholas Investments Partners | 1.7M | $1.7M | 0% | Dec 2023 |
|
| Barclays | 1.3M | $1.2M | 11% | Mar 2024 |
|
| Prospector Partners | 1.2M | $1.2M | 0% | Mar 2024 |
|
| Edmond De Rothschild Holding | 1.1M | $1.1M | 0% | Mar 2024 |
|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 1.0M | $984k | 100% | Mar 2024 |
|
| Calamos Advisors | 980k | $964k | -95% | Mar 2024 |
|
| Axa | 771k | $759k | 0% | Mar 2024 |
|
| Loomis, Sayles and | 469k | $41M | -19% | Mar 2024 |
|
| American Century Companies | 264k | $260k | 100% | Mar 2024 |
|
| Kohlberg Kravis Roberts & Co | 225k | $222k | 0% | Mar 2024 |
|
| Oppenheimer Asset Management | 151k | $148k | -43% | Mar 2024 |
|
| Stephens | 139k | $137k | 132% | Mar 2024 |
|
| Calamos Wealth Management | 134k | $132k | 24% | Mar 2024 |
|
| KBC Group NV | 100k | $99k | -50% | Mar 2024 |
|
| Brian McDonald | 80k | $79k | -1% | Mar 2024 |
|
| Us Bancorp | 73k | $72k | 0% | Mar 2024 |
|
| Stonegate Investment Group | 50k | $49k | 285% | Mar 2024 |
|
| Balboa Wealth Partners | 47k | $46k | 0% | Mar 2024 |
|
| Northwestern Mutual Wealth Management Company | 32k | $31k | 0% | Mar 2024 |
|
| Argent Trust | 25k | $25k | 0% | Mar 2024 |
|
| SG Americas Securities | 22k | $2.1M | 0% | Mar 2024 |
|
| Raymond James & Associates | 15k | $15k | 0% | Mar 2024 |
|
| Fox Hill Wealth Management | 11k | $11k | 100% | Mar 2024 |
|
| Candriam Luxembourg S.C.A. | 250.00 | $246k | 0% | Mar 2024 |
|
Who sold out of Biomarin Pharma Inc convertible/?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| OZ Management | Dec 2023 | 35M | $35M |
| Two Sigma Investments | Dec 2023 | 20M | $20M |
| Centiva Capital | Dec 2023 | 11M | $10M |
| RWC Asset Management | Dec 2023 | 10M | $9.9M |
| SSI Investment Management | Sep 2023 | 8.7M | $8.5M |
| Susquehanna International | Sep 2023 | 5.0M | $4.9M |
| BlackRock | Sep 2023 | 3.3M | $3.2M |
| La Banque Postale Asset Management SA | Dec 2023 | 2.2M | $2.1M |
| Worth Venture Partners | Dec 2023 | 910k | $899k |
| Russell Investments | Dec 2023 | 621k | $614k |
| Ofi Invest Asset Management | Sep 2023 | 3.0k | $2.9M |